Having trouble accessing articles? Reset your cache.

Bosutinib: Development discontinued

Pfizer Inc. (NYSE:PFE), New York, N.Y.
Product: Bosutinib ( SKI-606, PF-5208763); Celebrex celexcoxib ( YM177, Celecox); CP-533536 ( CP-533,536); dibotermin alfa;

Read the full 210 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE